Abstract:
Novel benzenedicarboxamides of the formula (I) wherein X represents hydrogen, halogen atom, nitro, C 1-6 alkylsulfonyloxy, C 1-6 alkylsulfinyl, C 1-6 alkylsulfenyl or C 1-6 alkylsulfonyl, R 1 represents C 1-6 alkyl, C 1-6 alkylthio-C 1-6 alkyl, C 1-6 alkylsulfinyl- C 1-6 alkyl or C 1-6 alkylsulfonyl- C 1-6 alkyl, Y represents halogen or C 1-6 alkyl, m represents 0 or 1, A represents O, S, SO, SO 2 , CH 2 or CH(CH 3 ), and Q represents a 5- or 6-membered heterocyclic group that contains at least one hetero atom selected from the group consisting of N, O and S and can be optionally substituted; processes for their preparation, their intermediates and their use as insecticides.
Abstract:
This invention provides compounds of Formula I, methods for their preparation and use for preparing compounds of Formula II wherein R¿1?, R¿2?, R¿3?, R¿5?, R¿6?, X and n are as defined in the disclosure. This invention also discloses preparation of compounds of Formula III wherein R¿1?, R¿2?, R¿7?, R¿8?, R¿9? and n are as defined in the disclosure. This invention also pertains to certain compounds of Formula 4 and 6 used to prepare compounds of Formula I, wherein R¿1?, R¿2?, R¿5?, X and n are as defined in the disclosure.
Abstract:
This invention provides compounds of Formula (1), their N-oxides and agriculturally suitable salts wherein R 1 , R 2 , R 3 , R 4a , R 4b and R 5 are as defined in the disclosure.Also disclosed are methods for controlling invertebrate pests comprising contacting the invertebrate pests or their environment with a biologically effective amount of a compound of Formula 1 or a composition comprising a compound of Formula 1.
Abstract:
This invention pertains to a method for controlling lepidopteran, homopteran, hemipteran, thysanopteran and coleopteran insect pests comprising contacting the insects or their environment with an arthropodicidally effective amount of a compound of Formula I, its N -oxide or an agriculturally suitable salt thereof wherein A and B and R 1 through R 8 are as defined in the disclosure. This invention further relates to a bezoxazinone compound of Formula (10), wherein R 4 through R 8 are as defined in the disc losure, useful for preparation of a compound of Formula I.
Abstract:
A method for the inhibition of high affinity glycine transporters, compounds that inhibit these transporters; pharmaceutically active compositions comprising such compounds; and the use of such compounds either as above, or in formulations for the control or prevention of disease states in which glycine is involved are disclosed.
Abstract:
The invention relates to novel compounds of formula (I) wherein R , R , R , R , X and Y have the meaning given in Claim 1. Said compounds are inhibitors of the coagulation factor Xa and can be used for the prophylaxis and/or therapy of thrombo-embolic diseases.
Abstract:
A compound of formula (I), where E is oxygen or sulphur; A is CR or N where R is hydrogen or hydrocarbyl; D completes a 5 or 6-membered non-aromatic heterocyclic ring which optionally contains additional heteroatoms selected from oxygen nitrogen or sulphur and which is optionally substituted by an optionally substituted lower hydrocarbyl group, or an optionally substituted heteroaryl group; R and R are each independently hydrogen, optionally substituted lower hydrocarbyl, or optionally substituted heteroaryl, or R and R together with the nitrogen atom to which they are attached, form a heterocyclic ring; Z represents halogen, optionally substituted lower hydrocarbyl, optionally substituted lower hydrocarbyloxy, optionally substituted lower hydrocarbylthio, hydrocarbylsulphinyl, or hydrocarbylsulphonyl, cyano, nitro, CHO, NHOH, ONR7'R7'', SF5, CO (optionally substituted lower hydrocarbyl), acylamino, COOR , SO2NR R , CONR R , OR or NR R where R , R , R , R , R , R and R are independently H or lower hydrocarbyl; R is hydrogen, SO2 lower hydrocarbyl or COR ; R and R are independently lower hydrocarbyl, lower hydrocarbyloxy or a group R ; R is OR , NR R , hydrogen or lower hydrocarbyl; R is lower hydrocarbyl, R and R are independently hydrogen or lower hydrocarbyl provided that when there are two or more substituents Z, they may be the same or different; and m is 0 or an integer from 1 to 5.
Abstract translation:式(I)化合物,其中E为氧或硫; A是CR 3或N,其中R 3是氢或烃基; D完成5或6元非芳族杂环,其任选地含有选自氧氮或硫的另外的杂原子,其任选被任选取代的低级烃基或任选取代的杂芳基取代; R 1和R 2各自独立地为氢,任选取代的低级烃基或任选取代的杂芳基,或R 1和R 2与它们所连接的氮原子一起形成杂环; Z表示卤素,任选取代的低级烃基,任选取代的低级烃氧基,任选取代的低级烃基硫代,烃基亚磺酰基或烃基磺酰基,氰基,硝基,CHO,NHOH,ONR7'R7“,SF5,CO(任选取代的低级烃基) COOR 7,SO 2 NR 8 R 9,CONR 10 R 11,OR 12或NR 13 R 14,其中R 7,R 7',R“ R“,R 9,R 10和R 11独立地为H或低级烃基; R 12是氢,SO 2低级烃基或COR 15; R 13和R 14独立地为低级烃基,低级烃氧基或R 12基团; R 15是OR 16,NR 17 R 18,氢或低级烃基; R 16是低级烃基,R 17和R 18独立地是氢或低级烃基,条件是当有两个或更多个取代基Z时,它们可以相同或不同; m为0或1〜5的整数。
Abstract:
Disclosed are compounds and methods of using compounds of the invention for treating a subject with a proliferative disorder, such as cancer, and methods for treating disorders responsive to Hsp70 induction and/or natural killer induction. Also, disclosed are pharmaceutical compositions comprising compounds of the invention and a pharmaceutically acceptable carrier.